comparemela.com

Latest Breaking News On - Practice guide update - Page 1 : comparemela.com

USPTO Says Serial and Parallel PTAB Petitions Have Declined

The United States Patent and Trademark Office (USPTO) has released an update to its study on multiple Patent Trial and Appeal Board (PTAB) petitions that it says demonstrates that serial and parallel petition practice at the PTAB has been decreasing since 2016, when the Office first issued guidance on the subject.

United-states
America
Aaric-eisenstein
Samsung-elecs
Canon-kabushiki-kaisha
Trademark-office
Rovi-guides-inc
Nvidia
Comcast-cable-commcns
Co-ltd
United-states-patent
Patent-trial

People With Silly Patents Would Really Like It If It Was Harder To Cancel Them

A large group of patent holders sent a letter to Congress expressing concern that, since the US Patent and Trademark Office (USPTO) Director Iancu might soon be leaving, recent policies making it harder to challenge bad patents might be reversed. The letter concerns a process created somewhat recently, called inter partes review (IPR), that allows…

Invega-sustenna
Thomas-jefferson
Daniel-takash
Trademark-office
Director-iancu
Overshoe-unit-for-indoor-use
Apparatus-and-method-for-manipulating
Spring-toy
Concealed-weapon
Remote-control-fishing-robot
Wallet-for-retaining
Practice-guide-update

Jones Day's Fintiv-ITC Developments Tracker - Intellectual Property

Jones Day's Fintiv-ITC Developments Tracker - Intellectual Property
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.

Canada
Canadian
Trevorm-jefferson
Jonm-jurgovan
Georgiannaw-braden
Nokia-technology
Allergan-inc
Solaria-corp
0x-genomics-inc
Laurmark-enterprises-inc
Bio-rad-labs-inc

PTAB Greenlights Three Petitions Against One Patent | Jones Day

two petitions against the same patent “should be rare” and that it is “unlikely that circumstances will arise where three or more petitions by a petitioner with respect to a particular patent will be appropriate.”  TPG Update at 26 (emphasis added).  In support of those statements, the PTAB explained that “one petition should be sufficient to challenge the claims of a patent in most situations” and that “[t]wo or more petitions filed against the same patent at or about the same time (e.g., before the first preliminary response by the patent owner) may place a substantial and unnecessary burden on the [PTAB] and the patent owner and could raise fairness, timing, and efficiency concerns.” 

Dolby-laboratories-inc
Intertrust-technologies-corp
Jones-day
Dolby-laboratories
Technologies-corp
Practice-guide-update
Intertrust-technologies
Following-dolby
டால்பி-ஆய்வகங்கள்-இன்க்
குறுக்கீடு-தொழில்நுட்பங்கள்-கார்ப்
ஜோன்ஸ்-நாள்

Proposed Novel PTAB Discretionary Denial Analysis in View of Parallel Petitions | Womble Bond Dickinson

Introduction The authors have recently proposed alternative analyses for the discretionary denial of IPR and PGR petitions involved in parallel district court litigation, as well as for the discretionary denial of serial petitions filed before the Patent Trial and Appeal Board (“PTAB”). The PTAB is also currently at a crossroads with yet a third similar but distinct issue the discretionary denial of parallel petitions filed before the PTAB. “Serial petitions” refer to multiple successive petitions challenging a particular patent that are filed by the same or different petitioners, whereas “parallel petitions” refer to multiple contemporaneous petitions challenging a particular patent that are filed by the same (or a related) petitioner. Although the PTAB has promulgated an analytical factor-based framework for evaluating the discretionary denial of serial petitions, the PTAB has not done so for parallel petitions. Rather, the Board has simply issued general guidance th

Canada
Canon-kabushiki-kaisha
See-chegg-inc
Co-ltd
Incom-corp
Walt-disney-co
0x-genomics-inc
Bio-rad-labs-inc
Trademark-office
Canada-inc
Apple-inc
Fintiv-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.